butabarbital decreases effects of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers could minimize sufentanil amounts and efficacy, probably precipitating withdrawal syndrome in individuals that have d